Tomorrow’s Cure: How DNA guides cancer detection

This content is courtesy of Mayo Clinic, the No. 1 hospital in the world according to Newsweek. Minnesota Oncology is a member of the Mayo Clinic Care Network. This relationship provides us with access to information, knowledge and expertise from Mayo Clinic..

What if you knew you'd get sick before you ever felt symptoms? If it was a cold, that information is useful. In the case of cancer, it is lifesaving. This week's podcast episode of Tomorrow's Cure explores how DNA could be used to detect blood cancers before they ever develop.

Episode experts include Dr. Mrinal Patnaik, a hematologist, internist and oncologist at Mayo Clinic; and Dr. Kelly Bolton, an oncologist at Washington University in St. Louis.

"We're developing tests where we can actually detect the early first step in the multistep progression to cancer," Dr. Bolton says. "That's an area where we might be able to intervene on someone's genetic changes that haven't quite led to cancer, but that are very high risk of becoming a cancer."

"When we detect clonal hematopoiesis, we want to nip it in the bud and prevent those high-risk patients from developing blood cancer because they are often lethal, difficult to treat. So the earlier we can effectively and safely intervene, the better for the patients,” says Dr. Patnaik.

DNA.png

WATCH THE VIDEO

Share

Categories

Tags

Recent Posts

#
April 30, 2026

Clinical trials are essential to advancing cancer care. Learn what clinical trials are, how they work, and how they help improve treatment options for patients.

#
April 22, 2026

“Minnesota Oncology listens. You are heard. Any concern you have, they do their best to answer it,” she said. “I am so thankful for everyone at Minnesota Oncology – Dr. Vera, Syndey, the schedulers, infusion nurses, everyone at the Maple Grove clinic. You feel at home there, which is hard to do when you are going through treatment. Minnesota Oncology treats you like family.”

#
April 8, 2026

Testicular cancer happens when cancer cells grow in one or both testicles. It is not very common. About 1 in 250 men will get testicular cancer during their lifetime.